MedPath

Assessing Interest in Web/App Platforms for Early Phase Clinical Trial Recruitment

Not yet recruiting
Conditions
Assessing Interest in a Platform for Early Phase Clinical Trial Recruitment
Registration Number
NCT06302647
Lead Sponsor
Instituto de Investigación Hospital Universitario La Paz
Brief Summary

Study objective:

To assess whether the different stakeholders (volunteers, patients, doctors and industry) involved in early phase trials would be interested in using a platform to facilitate recruitment and engagement in this type of trials. In addition, we will also evaluate the degree of awareness existing in society about clinical trials.

Study subjects: General population, patient, physicians, pharmaceutical-biotechnological industry.

Keywords: healthy volunteer, patient, pharma industry, patient associaiton, questionnaire, clinical trial, platform, recruitment, engagement.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Participant will be over 18 years old.
  • Male, female or do not want to specify.
  • Participants will be capable to understand spanish language.
  • Subjects able to communicate with the investigator and able to read and write and follow all study instructions.
Exclusion Criteria
  • Individuals not willing to complete the eraly phase clinical trial platform Study survey
  • Individuals who do not meet eligibility criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
percentage of each of the three groups that would find the platform useful3 months

It would be deemed useful if they respond affirmatively or, in the case of a numerical scale from 1 to 5 being 1 the worse o low results and 5 the best or highest, if rate it above 4 in 80% of the questions regarding the utility of the platform.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.